Missed a GLP-1 Dose? Late Doses and Restarting Explained

What to do after missing a GLP-1 dose depends on the exact medicine, formulation and how long it has been. Use the instructions for your prescribed product and contact your pharmacist or prescriber when uncertain. A rule for one late injection does not establish how to restart after several missed weeks.

The useful first step is identifying your medication, rather than searching for a universal number of days. Semaglutide is sold in different branded products, and compounded products need instructions from the treating clinician and dispensing pharmacy. Keep your carton or prescription label in front of you when asking for help.

Why is there no single missed-dose rule?

Wegovy, Ozempic and Zepbound do not all use the same timing instructions. An oral product also should not inherit the directions for an injection. The current U.S. label for the exact product is the reference; instructions from a friend using a different medicine are not enough.^1,2,3

This table identifies which instructions to find; it is not a replacement dosing schedule. Confirm the presentation as well as the brand. A new device or a switch between a tablet and injection can change the instructions you need.

What do the branded labels say about one missed dose?

The Wegovy injection label distinguishes whether the next scheduled dose is more than 48 hours away. Its tablet instructions instead direct the patient to skip a missed tablet and resume the next day. The label separately addresses multiple missed injections.¹

Ozempic's U.S. prescribing information describes taking a missed injection within five days; after that, the missed dose is skipped and the regular schedule resumes.² Zepbound's U.S. label uses a four-day window and specifies at least 72 hours between doses when changing the administration day.³

Those are summaries of different labels, not permission to choose whichever window is most convenient. Read the full instructions for your product. Do not take an extra dose to compensate without direction, and contact the pharmacist if the timing is unclear. If your prescription instructions conflict with the package, ask the clinician and pharmacy to reconcile them before acting.

What changes after a longer break?

After several missed doses, the question may be how to restart rather than whether one late injection can still be taken. The duration of the interruption, previous tolerability and your current health are information for the prescriber. A dose tolerated before the gap is not automatically the right next step afterward.

Wegovy's label specifically discusses reinitiation after two or more consecutive missed injections. Do not extend that product's instructions into an unsourced restart chart for every GLP-1.¹ Zepbound and Ozempic patients should ask their treating clinician how to handle a prolonged interruption rather than infer a restart dose from a routine late-dose paragraph.

If the medication is used for diabetes, tell the clinician about the interruption and ask how the rest of your treatment plan should be managed. Do not independently change insulin or another medicine to compensate. Treatment interruptions can involve more than appetite or weight management.

What should you tell the pharmacist or prescriber?

Give dates rather than saying that you missed a little while. Explain what you have taken, what remains and why the gap happened. An accurate account makes it easier to distinguish a calendar problem from a side-effect, prescribing or delivery problem.

For a compounded vial, also give the concentration printed on the label. A syringe-unit number by itself does not identify a dose in mg. Our units-to-mg guide explains that distinction. It cannot replace the pharmacy's instructions for the vial you have.

What if you are not sure whether you took the dose?

An uncertain dose is different from a definitely missed one. Do not resolve uncertainty by automatically taking another injection. Check your medication log, the device instructions and any record you keep, then contact the pharmacist or prescriber with the details.

For a suspected extra dose or dosing error, seek prompt advice from a pharmacist, clinician or poison-control service. If you have severe symptoms or an emergency, obtain urgent medical care. Save the packaging and record what may have been taken so that the clinician can assess the exposure.

A reminder system can reduce future uncertainty. Use a calendar entry after taking the medicine, rather than marking it in advance. If another person helps with administration, agree on one shared record. The aim is an accurate history, not merely a notification that is easy to dismiss.

How should you handle a refill delay?

Contact the program as soon as the expected refill looks uncertain. Ask whether the prescription has been approved, whether the pharmacy has accepted it and whether the carrier has the package. Those are different steps, and a generic order status may not explain which one is delayed.

Tell the clinical team when your next dose is due and how much usable medicine remains. Ask what to do if the shipment arrives after that date. Do not shorten intervals, draw leftover amounts or use another person's medication to bridge the gap. A delivery problem needs an explicit treatment plan if it becomes an interruption.

If you decide to change companies, our provider transfer checklist explains the records and billing handoff. Changing seller does not remove the need for a new clinician to assess a restart after a gap.

What if a procedure caused the pause?

If the medication was paused for surgery or a procedure, ask the team that set the pause when to resume and whether the prescriber needs to reassess the dose. Do not treat the end of the procedure as automatic clearance to return to the old schedule.

Our GLP-1 and anesthesia guide explains why the surgical and prescribing teams need a coordinated plan. Keep the written instructions, especially when the anesthesiologist, surgeon and online prescriber work in separate systems. If their advice appears inconsistent, ask them to reconcile it.

Can you use medicine left from an earlier shipment?

Check the exact product's expiry, storage and in-use instructions with the pharmacist. Remaining liquid is not proof that it is appropriate to use. A vial or device may have a shorter usable period after first use, and an earlier concentration can differ from a new prescription.

The storage guide explains why temperature and the product's own instructions matter. If a shipment arrived warm or you do not know how an old vial was stored, provide that history to the dispensing pharmacy. Do not assume it can be made usable by refrigerating it again.

What should a clear restart plan contain?

Ask the clinician to state the exact product, next dose, date and any follow-up. Confirm whether a new prescription is required and whether your remaining supply matches it. Have the pharmacist explain any unfamiliar preparation or device instructions.

Keep a copy of that plan alongside your treatment record. If symptoms recur, explain the interruption and restart rather than reporting only the latest dose. For broader background on tolerability, see GLP-1 side effects. The aim is a plan based on what you actually took, with a reliable refill process to prevent the same gap happening again.

An example: the refill arrives after the scheduled day

Suppose a package arrives several days late. Before using a late-dose rule, confirm the exact product and the date you actually took the previous dose. A scheduled calendar reminder is not proof that the last injection happened. If there were other missed weeks before the shipping delay, tell the clinician about the whole interruption.

Next, distinguish a usable package from an uncertain shipment. If the medicine arrived outside its required storage conditions, ask the pharmacy about the product before making the timing decision. Having a box in hand does not resolve a temperature concern.

Finally, obtain a next-dose plan and record the new schedule if it changes. Ask the program what will prevent the next refill from repeating the delay. A temporary dosing answer solves this week's timing question; an earlier refill review or clearer pharmacy communication may be needed to solve the recurring administrative problem.